Apotex Biosimilar Notice To Amgen Is Mandatory, Judge Says
A Florida federal judge on Wednesday found that biosimilar makers must always provide 180-day notice of sales to brand-name rivals when using a streamlined approval pathway, a milestone ruling that would...To view the full article, register now.
Already a subscriber? Click here to view full article